FAKTOR OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Boerse Frankfurt Warrants 03:50:29 2024-07-05 pm EDT | ||
| 10.45 EUR | +4.71% |
|
| Current month | -2.91% | ||
| 1 month | +15.88% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 10.36 | +3.81% |
| 24-07-04 | 9.98 | +0.20% |
| 24-07-03 | 9.96 | -2.06% |
| 24-07-02 | 10.17 | +2.21% |
| 24-07-01 | 9.95 | -6.75% |
Real-time Boerse Frankfurt Warrants
Last update July 05, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PE3EDW |
| ISIN | DE000PE3EDW0 |
| Date issued | 2022-03-11 |
| Strike | 91.08 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 90.69 € |
|---|---|
| Lowest since issue | 3.93 € |
| Spread | 0.1 € |
| Spread % | 0.95% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
92.32
USD
Average target price
96.13
USD
Spread / Average Target
+4.12%
- Stock Market
- Certificates
- Certificat
